Telmisartan and losartan: The marked differences between their chemical and pharmacological properties may explain the difference in therapeutic efficacy in hospitalized patients with COVID-19.
Pharmacol Res Perspect
; 11(2): e01083, 2023 04.
Article
em En
| MEDLINE
| ID: mdl-37038324
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
COVID-19
/
Hipertensão
Limite:
Humans
Idioma:
En
Revista:
Pharmacol Res Perspect
Ano de publicação:
2023
Tipo de documento:
Article